A practical guide to the management of dyslipidaemia – Clinical Research in Cardiology Review (2026) Patrick M. Siegel

Description

Dyslipidaemia, especially elevated low-density lipoprotein cholesterol (LDL-C), is a major modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD). This paper highlights key lipid parameters (triglycerides and lipoprotein(a)), provides practical guidance for diagnostic challenges and cardiovascular risk assessment, and reviews current management strategies. It incorporates key messages from the 2025 Focused Update of the 2019 ESC/EAS guidelines, including the consideration of cardiovascular risk modifiers and the use of potent early combination therapy after acute coronary syndrome.